Phillip Bergen
Cited by
Cited by
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
PJ Bergen, J Li, CR Rayner, RL Nation
Antimicrobial agents and chemotherapy 50 (6), 1953-1958, 2006
Pharmacokinetics and pharmacodynamics of ‘old’polymyxins: what is new?
PJ Bergen, CB Landersdorfer, J Zhang, M Zhao, HJ Lee, RL Nation, J Li
Diagnostic microbiology and infectious disease 74 (3), 213-223, 2012
Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model
PJ Bergen, JB Bulitta, A Forrest, BT Tsuji, J Li, RL Nation
Antimicrobial agents and chemotherapy 54 (9), 3783-3789, 2010
Comparison of once-, twice-and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro …
PJ Bergen, J Li, RL Nation, JD Turnidge, K Coulthard, RW Milne
Journal of Antimicrobial Chemotherapy 61 (3), 636-642, 2008
Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at …
PJ Bergen, A Forrest, JB Bulitta, BT Tsuji, HE Sidjabat, DL Paterson, J Li, ...
Antimicrobial agents and chemotherapy 55 (11), 5134-5142, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model
PJ Bergen, BT Tsuji, JB Bulitta, A Forrest, J Jacob, HE Sidjabat, ...
Antimicrobial agents and chemotherapy 55 (12), 5685-5695, 2011
‘Old’antibiotics for emerging multidrug-resistant bacteria
PJ Bergen, CB Landersdorfer, HJ Lee, J Li, RL Nation
Current opinion in infectious diseases 25 (6), 626, 2012
The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic …
ZZ Deris, HH Yu, K Davis, RL Soon, J Jacob, CK Ku, A Poudyal, ...
Antimicrobial agents and chemotherapy 56 (10), 5103-5112, 2012
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
TB Tran, T Velkov, RL Nation, A Forrest, BT Tsuji, PJ Bergen, J Li
International journal of antimicrobial agents 48 (6), 592-597, 2016
Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic …
HJ Lee, PJ Bergen, JB Bulitta, B Tsuji, A Forrest, RL Nation, J Li
Antimicrobial agents and chemotherapy 57 (8), 3738-3745, 2013
Dosing of colistin—back to basic PK/PD
PJ Bergen, J Li, RL Nation
Current opinion in pharmacology 11 (5), 464-469, 2011
Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two ‘old’ antibiotics—polymyxin B and chloramphenicol
N Abdul Rahim, SE Cheah, MD Johnson, H Yu, HE Sidjabat, J Boyce, ...
Journal of Antimicrobial Chemotherapy 70 (9), 2589-2597, 2015
In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa
CC Walsh, MP McIntosh, AY Peleg, CM Kirkpatrick, PJ Bergen
Journal of Antimicrobial Chemotherapy 70 (11), 3042-3050, 2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
NS Ly, JB Bulitta, GG Rao, CB Landersdorfer, PN Holden, A Forrest, ...
Journal of antimicrobial chemotherapy 70 (5), 1434-1442, 2015
Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm …
J Lora-Tamayo, O Murillo, PJ Bergen, RL Nation, A Poudyal, X Luo, ...
Journal of antimicrobial chemotherapy 69 (9), 2434-2442, 2014
An “unlikely” pair: the antimicrobial synergy of polymyxin B in combination with the cystic fibrosis transmembrane conductance regulator drugs KALYDECO and ORKAMBI
EK Schneider, MAK Azad, ML Han, Q Zhou, J Wang, JX Huang, ...
ACS infectious diseases 2 (7), 478-488, 2016
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use
PJ Bergen, ZP Bulman, S Saju, JB Bulitta, C Landersdorfer, A Forrest, J Li, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (1 …, 2015
PK/PD models in antibacterial development
T Velkov, PJ Bergen, J Lora-Tamayo, CB Landersdorfer, J Li
Current opinion in microbiology 16 (5), 573-579, 2013
Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae
M Zhao, ZP Bulman, JR Lenhard, MJ Satlin, BN Kreiswirth, TJ Walsh, ...
Journal of Antimicrobial Chemotherapy 72 (7), 1985-1990, 2017
Optimizing polymyxin combinations against resistant gram-negative bacteria
PJ Bergen, ZP Bulman, CB Landersdorfer, N Smith, JR Lenhard, ...
Infectious diseases and therapy 4 (4), 391-415, 2015
The system can't perform the operation now. Try again later.
Articles 1–20